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ABSTRACT
Purpose: The purpose of this project was to examine the effects of acute garlic supplementation
on fibrinolytic potential and the fibrinolytic response to exercise in young healthy trained males.
Methods: 18 healthy trained males (Age = 20.9 ± 2.2 years, Height = 178 ± 7.7 cm, Weight =
75.5 ± 9.6 kg, VO2max = 59.8 ± 6.7 ml kg-1 min-1) performed a graded treadmill test to volitional
exhaustion. Blood samples were taken at rest, within two minutes post-exercise, and one hour
post-exercise. Participants were randomly assigned to ingest either 900 mg of powdered garlic or
a placebo three hours before the exercise session. The supplement was distributed in a doubleblind, crossover fashion. Participants repeated the protocol with the other treatment after a 14day washout period. Paired t-tests were used to compare height, weight, resting hematocrit,
VO2max, respiratory exchange ratio, and treadmill time between the two trials. A two-factor
(treatment and time) repeated measures analysis of variance (ANOVA) was used to assess
changes in tPA activity, tPA antigen, and PAI-1 activity. A priori statistical significance was set
at P <0.05. Results: A significant difference was found between the two treatment conditions for
absolute and relative VO2max. No significant differences were observed between the two
treatment conditions for treadmill time or respiratory exchange ratio at VO2max. There was no
main effect for treatment and no treatment x time interaction for any of the fibrinolytic variables
examined. Conclusion: Acute garlic supplementation does not alter fibrinolytic potential or the
fibrinolytic response to exercise in young healthy trained males. Acute garlic supplementation
does, however, cause a small but statistically significant increase in VO2max. It remains unclear
if this increase in VO2max is of functional importance.
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Chapter One
Introduction
The relative risk of myocardial infarction is 5.9 fold greater in the hour after vigorous
exercise (Mittleman, et al. 1993). In the general population, the mechanism triggering the
majority of cardiovascular events is the disruption of a vulnerable atherosclerotic plaque resulting
in an occlusive thrombus (Giri et al., 1999) and studies examining individuals with exertionrelated myocardial infarctions suggest a similar pathological process (Ciampricotti et al., 1990).
Consequently, the post-exercise period may be a hazardous time for those at risk of coronary
events. One of the major factors which determines if an atheroscleoritc plaque will become
occlusive is the hemostatic balance in the blood (Nagelkirk, 2010). Since 4% to 15% of
myocardial infarctions are exertion-related (Tofler, 1990), methods which reduce prothrombotic
or increase antithrombotic hemostatic forces during exercise may be clinically significant.
Fibrinolysis, defined as the capacity to lyse insoluble fibrin clots, is primarily regulated
by tissue plasminogen activator (tPA) (Collen & Lijnen, 1986) and the main circulating inhibitor
of tPA; plasminogen activator inhibitor-1 (PAI-1) (Schleef & Loskutoff, 1988). tPA is a serine
protease that activates the fibrinolytic system by converting the pro-enzyme plasminogen to the
active enzyme plasmin, which then subsequently dissolves fibrin into fibrin degradation products
(Gebbink, 2011). tPA is stored in small vesicles within vascular endothelial cells (Emeis et al.,
1997) and is released in the presence of a variety of stimuli, especially increased levels of
epinephrine (Chandler et al., 1992). PAI-1 is a serine protease inhibitor that inhibits the
fibrinolytic system by acting as a substrate to tPA. The resulting cleavage of PAI-1 by tPA results
in covalent binding of PAI-1 to tPA in a stable inactive 1:1: stochiometric complex (Gebbink,
2011).
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PAI-1 is produced by endothelial cells in an active form and is then secreted into the
blood where it rapidly forms an inactive complex with tPA or it is released into the
subendothelium where it binds to the extracellular matrix (Schleef & Loskutoff, 1988). PAI-1 is
also produced by adipocytes in response to habitual elevations in tumor necrosis factor, insulin,
and transforming growth factor beta (Alessi & Juhan-Vague, 2006). Regulation of PAI-1 occurs
through a variety of mechanisms including endotoxin, thrombin, transforming growth factor β,
and inflammatory cytokines (Schleef & Loskutoff, 1988). Coagulation, defined as the capacity to
form insoluble fibrin clots, is achieved through a sequential process by which multiple inactive
coagulation factors are converted to their active enzymatic form (Smith, 2003), ultimately
resulting in conversion of prothrombin to thrombin. During exercise, markers of coagulation rise
and remain elevated for hours into the post-exercise period (Hansen et al, 1990; Van Den Burg et
al., 1995; Vanden Burg et al. 1997; Weiss et al. 1998; Hedge et al. 2000; Hillberg et al, 2003;
Hillberg et al., 2003; Paton et al. 2004; Acil et al., 2007). Fibrinolysis also increases during
exercise and thus maintains a balanced hemostatic environment (Chandler et al., 1992; Van Den
Burg et al., 1995; Symanski et al., 1996; Van Den Burg et al., 1997; Fernhall et al. 1998; Hedge
et al., 2000, Womack et al., 2001, Womack et al, 2003). However, at the cessation of exercise,
fibrinolysis decreases rapidly (Hansen et al. 1990; Van Den Burg et al. 1995; Van Den Burg et
al., 1997; Weiss et al. 1998; Cooper et al., 2004) and one hour post-exercise there is no longer
any enhancement of the fibrinolytic system (Hilberg et al. 2003; Paton et al., 2004; Womack et
al., 2006). This subsequently results in a hemostatic imbalance during the post-exercise period
that favors clot formation.
For thousands of years the benefits of Garlic, Allium sativum, have been recognized and
included in clinical treatment. In the codex of Ebers, an ancient Egyptian medical writing, garlic
is written as an essential ingredient in 22 therapeutic formulas (Block, 1985). Hippocrates
observed garlic to be an effective treatment for neoplasms as well as an effective diuretic (Singh
& Singh, 2008). The Roman physician Dios-corides prescribed garlic as vermifuge to the Roman

3

army (Block, 1985). The prophet Mohammad recommended garlic as a treatment for scorpion
stings (Singh & Singh, 2008). In modern times, Garlic still has the reputation of a highly
recognized medicinal plant. In the two world wars, garlic was used as an antiseptic agent to treat
wounds and prevent gangrene (Essman, 1984; Block, 1985). In 1944 Cavallito & colleagues
identified this antiseptic component of garlic and it subsequently became the subject of two US
patents (Block, 1985; Amagase et al., 2001). Albert Schweitzer reported to have used garlic as a
medical treatment for amoebic dysentery (Block, 1985).
There are >3,000 scholarly publications which have examined and confirmed numerous
therapeutic properties garlic (Amagase et al., 2001). One benefit is garlic’s ability to improve
fibrinolysis. Studies from the late 1970s to early 1990s reported substantial increases in
fibrinolytic activity after acute and chronic supplementation (Bordia et al., 1975; Bordia et al.,
1977, Bordia et al., 1978, Arora et al., 1981, Chutani & Bordia, 1981; Bordia et al., 1982;
Gadkari et al. 1991). These studies also found garlic to be effective at enhancing fibrinolytic
activity across a variety of forms including: raw garlic (Chutani & Bordia, 1981; Gadkari et al.,
1991), fried garlic (Chutani & Bordia, 1981), and the essential oil of garlic (Bordia et al., 1975;
Bordia et al., 1978; Arora et al., 1981; Bordia et al., 1982). Although the results of these studies
are encouraging, they are limited because they fail to identify the specific parts of the fibrinolytic
system that are affected by garlic. This limitation is inherently derived from the use of the
euglobulin clot lysis method of measuring fibrinolytic activity (Kowalski et al., 1959) instead of
directly measuring changes in tPA and PAI-I levels. There are also no prior studies which have
combined exercise with garlic supplementation to evaluate the fibrinolytic effects of garlic during
the post-exercise period.
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Aims and Hypothesis
Aim 1- To determine if acute supplementation with garlic influences plasma tPA levels at rest,
within 2-minutes following a cardiorespiratory fitness test, and 1-hour after completion of a
cardiorespiratory fitness test as compared to a placebo.
Hypothesis 1- Acute supplementation with garlic will increase plasma tPA activity and decrease
plasma tPA antigen at rest and will elevate tPA activity and tPA antigen levels within 2-minutes
following a cardiorespiratory fitness test and 1-hour after completion of a cardiorespiratory
fitness test as compared to a placebo.
Aim 2- To determine if acute supplementation with garlic influences plasma PAI-1 levels at rest,
within 2-minutes following a cardiorespiratory fitness test, and 1-hour after completion of a
cardiorespiratory fitness test as compared to a placebo.
Hypothesis 2- Acute supplementation with garlic will decrease plasma PAI-1 levels at rest, within
2-minutes following a cardiorespiratory fitness test, and 1-hour after completion of a
cardiorespiratory fitness test as compared to a placebo.
Significance of this Study
To date only three studies have examined the effect of acute garlic supplementation on
tPA levels in humans (Kiesewettier et al., 1990; Jung et al., 1991; Legnani et al., 1993). Only two
studies have evaluated the effect of acute garlic supplementation on PAI-1 activity (Jung et al.,
1991; Legnani et al., 1993). Yet, there is no overall consensus between them regarding the ability
of acute supplementation to enhance fibrinolytic potential. Kiesewettier & colleagues observed
300 mg and 600 mg of powdered garlic to increase tPA activity 56% and 51%, respectively, after
5 hours. Moreover, the 600 mg of powdered garlic was shown to improve tPA activity in all
participants. Jung & colleagues in a similar study observed 900 mg of dried garlic to enhance tPA
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activity by 86% after 5 hours. In contrast to these two studies, Legnani & colleagues administered
900 mg of dried garlic powder and observed no significant change in tPA activity or antigen after
2, 4, and 6 hours.
It should also be realized that all of these studies had female participants (Kiesewettier et
al., 1990; Jung et al., 1991; Legnani et al., 1993) and two of the studies had participants who were
active tobacco smokers (Jung et al., 1991; Legnani et al., 1993). Cederblad et al. (1977) and
Giardina et al., (2004) have observed fibrinolytic activity to be variable across the menstrual
cycle. None of the three studies indicated if they standardized their female participants’ treatment
trials to menstrual cycle status. Research has also shown smoking tobacco alters fibrinolysis by
decreasing tPA activity and antigen levels (Newby et al., 1999; Pretorius et al., 2002) and also by
decreasing the tPA/PAI-1 molar ratio (Barua et al., 2002). These two factors were controlled for
in the present study.
An additional strength of the current study is that it uniquely maximizes the potential to
detect a difference between trials. Basal tPA and PAI-1 activity levels are low (Rijken et al.,
1983; Declerck et al., 1988). This necessitates either a large effect size or a large number of
participants to detect differences in these variables at rest. Large changes in fibrinolysis occur
when stress is applied to the cardiovascular system. Research has shown exercise to be a
sufficient stress to observe differences in fibrinolytic potential between groups that are not readily
available at rest (Hamouradtidis et al., 1988). Thus, exercise may increase the potential to observe
differences in the fibrinolytic profile between the garlic and placebo trials. Lastly, the effects of
garlic on the exercise induced alterations in fibrinolysis are not known.

Chapter Two
Review of the Literature
Objective
The objective of this chapter is to provide an overview of: 1) the effects of garlic
supplementation on fibrinolytic potential, 2) the effects of acute exercise on fibrinolytic potential,
3) the effects of acute exercise on coagulation potential, and 4) the methodological considerations
for research involving hemostasis.
Regulation of Fibrinolysis
Fibrinolysis, defined as the capacity to lyse insoluble fibrin clots, is primarily regulated
by tissue plasminogen activator (tPA) (Collen & Lijnen, 1986) and the main circulating inhibitor
of tPA; plasminogen activator inhibitor-1 (PAI-1) (Schleef & Loskutoff, 1988). tPA is a protease
which activates the fibrinolytic system through the conversion of the pro-enzyme plasminogen to
the active enzyme plasmin (Gebbink, 2011). This subsequently results in the dissolution of fibrin
into fibrin degradation products (Gebbink, 2011). tPA is stored within vascular endothelial cells
(Emeis et al., 1997) and is released from the endothelium in response to a variety of stimuli.
However, in regards to exercise, approximately half of the tPA release is due to increased
circulation of epinephrine (Chandler et al., 1992).
PAI-1 is a protease inhibitor, which inhibits the fibrinolytic system by acting as a
substrate to tPA. Upon cleavage of PAI-1 by tPA, a covalent bond forms between the two
producing an inactive complex (Gebbink, 2011). PAI-1 is also produced by endothelial cells in an
active form and is then secreted into the blood where it rapidly forms an inactive complex with
tPA (Schleef & Loskutoff, 1988). PAI-1 is also produced by adipocytes in response to habitual
elevations in tumor necrosis factor, insulin, and transforming growth factor beta (Alessi & JuhanVague 2006). Like tPA, the regulation of PAI-1 occurs through a variety of mechanisms
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including endotoxin, thrombin, transforming growth factor β, and inflammatory cytokines
(Schleef & Loskutoff, 1988).
Effects of Garlic on Fibrinolysis
Studies dating back to the late 1970s have demonstrated that garlic has the ability to
positively affect fibrinolytic potential (Bordia et al., 1975; Bordia et al., 1977, Bordia et al., 1978,
Arora et al., 1981, Chutani & Bordia, 1981; Bordia et al., 1982; Gadkari et al. 1991; Bordia et al.,
1998). These studies observed a wide range (15-130%) of fibrinolytic enhancement (Bordia et al.,
1975; Bordia et al., 1977; Bordia et al., 1978). This large range of observed values may be due to
differences in dosage form. The essential oil of garlic (Bordia et al., 1975; Bordia et al, 1978;
Arora et al., 1981) produced larger increases in fibrinolytic activity as compared to fried garlic
(Chutani & Bordia, 1981;) and garlic with butter (Bordia et al., 1975; Bordia et al. 1982). This
may be due to the fact that consuming a fatty diet produces hyperlipemia, which has been
postulated to impair fibrinolytic potential (Bordia et al., 1975; Bordia et al., 1982). Luley &
colleagues (1986) used dried garlic; however, no improvements in fibrinolytic potential were
observed with its administration. The large range of observed values may also be due to
differences in dosage amount. Bordia and colleagues (1977, 1978) observed a 130% in
fibrinolytic activity, after three months of supplementing 1 gram of garlic oil per kilogram of
bodyweight daily. Conversely, Gadkari and colleagues (1991) observed a smaller increase in
fibrinolytic activity (21.8%) after 2 months of dosing with 10 grams of raw garlic daily.
Similarly, Arora and colleagues (1981) used a smaller dose, 3.75 milligrams of garlic oil daily,
which results in an observed 32.5% increase in fibrinolytic activity by 8 weeks.
Interestingly, the literature also shows that garlic can enhance fibrinolytic activity after
acute doses. Bordia and colleagues (1975) administered 50 grams of garlic along with 100 grams
of butter to 10 healthy subjects. After 3 hours there was a 15% increase in fibrinolytic activity.
Within the same study on a separate trial, men were fed 100g of butter and over the same time
course saw a 49% decline in fibrinolytic activity. This strongly suggests an acute ability of garlic
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to enhance the fibrinolytic system. Similarly, Chutani & Bordia (1981) compared the effect of
fried and raw garlic on fibrinolytic activity in 20 patients with ischemic heart disease. Garlic was
administered in the morning in fried or raw doses amounting to 0.5 grams per kilogram of body
weight. Fibrinolytic activity increased in the control group by 5% after 6 hours; however, this
difference was not significant. In the experimental trials, fibrinolytic activity significantly
increased by 72% and 63% six hours following the administration of raw and fried garlic,
respectively. Moreover, these elevated levels of fibrinolytic activity were maintained up to 12
hours after administration.
The aforementioned studies strongly support the hypothesis that garlic supplementation
can enhance the fibrinolytic system. However, the specific targets of improvement in the
fibrinolytic system are unknown due to the use of euglobulin clot lysis time in these studies. The
euglobulin clot lysis method is a technique that calls for the generation of a standard clot followed
by recording the lysis time of said clot (Kowalski et al., 1958). This provides an adequate
assessment of overall fibrinolytic activity; however, it does not allow researchers to specifically
identify the aspects of the fibrinolytic system that are being altered by garlic supplementation.
More recent studies have attempted to bypass this limitation by directly measuring tPA and PAI-1
levels before and after garlic administration. Kiesewttier & colleagues (1990) administered single
doses of 100 mg, 300 mg, and 600 mg of powdered garlic or placebo orally. Five hours following
administration they observed a 56.3% and 51% increase in tPA activity in the 300 mg and 600 mg
trials, respectively. Despite the similarities in overall percent increase, the 600 mg trial was the
only dose that led to increased activity in all participants. Jung & colleagues (1991) similarly
administered single doses of 900 mg of powdered garlic or placebo. Five hours after
administration, tPA activity rose 86.1%. Legnani & colleagues (1993) administered a single dose
of 900 mg of powdered garlic as well. tPA activity levels increased 300% after 4 hours and 406%
after 6 hours. PAI-1 was investigated by both Jung et al (1991) and Legnani et al (1993),
however, neither research group reported any significant changes in this variable.
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Increased tPA activity could explain the shortening of the euglobulin clot lysis time
observed with garlic supplementation. However, it should also be realized that fibrinolytic
potential has pronounced circadian variations (Angleton et al., 1988). PAI-1 activity and tPA
antigen are significantly higher in the morning as compared to evening values (Angleton et al.,
1988). In contrast, tPA activity is significantly lower in the morning and inversely correlated (r=0.57) with PAI-1 activity (Angleton et al., 1988). Therefore, a portion of the impressive increases
in tPA activity observed by these studies was due to normal diurnal variations rather than garlic
supplementation. In support of this, tPA activity increased 35% and 31.4% in the placebo trials,
in the Kiesewettier and colleagues (1991) and Jung and colleagues (1991) studies.
It should also be noted that these studies had female participants (Kiesewetter et al.,
1990; Jung et al., 1991; Legnani et al., 1993) and participants who were active tobacco smokers
(Jung et al., 1991; Legnani et al., 1993). Cederblad et al. (1977) and Giardina et al. (2004) have
observed fibrinolytic activity to be variable across the menstrual cycle. None of the three studies
indicated if they standardized their female participants’ treatment trials to menstrual cycle status.
Research has also shown smoking tobacco alters fibrinolysis by decreasing tPA activity and
antigen levels (Newby et al., 1999; Pretorius et al., 2002) and also by decreasing the tPA/PAI-1
molar ratio (Barua et al., 2002). These two factors were controlled for in the present study.
Fukao & colleagues (2007) uniquely examined the effects of garlic administration on
markers in tPA and PAI-1 in vitro by using cultured human umbilical vein endothelial cells
(HUVECs), fibrin film, and chromogenic assays. They observed that garlic preparations at the
concentrations of 0.4 µg*mL-1, 100 µg*mL-1, 500 µg*mL-1, and 1 mg*mL-1 did not influence tPA
or PAI-1 secretions from the HUVECs. However, when tPA was incubated with garlic on a fibrin
film, the lysis area of fibrin increased 1.8x as a result of increased degradation of fibrin by tPA
mediated activation of plasminogen. The assay also demonstrated increased plasmin generation
by tPA in the presence of garlic. Kinetic analysis showed that the maximum velocity achieved by
the enzymatic system (Vmax) did not change but that the substrate concentration required to reach
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half of Vmax decreased with garlic. The efficiency of the enzymatic reaction between tPA and
plasminogen was also found to be enhanced which resulted in an 8.7x increase in total reactivity.
Together these findings suggest garlic does not increase the secretion of tPA from the vascular
endothelium but rather acts as a cofactor that increases the affinity between tPA and plasminogen.
Harenberg and colleagues (1988) also conducted a unique study of the effects of garlic
supplementation on fibrinoylsis. The researchers measured concentrations of fibrinopeptide Bβ 142 in the blood following administration of 600 mg of dried garlic for 4 weeks in a group of 20
out-patients with hyperlipoproteinemia. Fibrinopeptide Bβ1-42 is a product of the lysis of fibrin
by plasmin (Nossel et al., 1979). Thus, the concentration of fibrinopeptide Bβ 1-42 in the blood is
an indicator of the magnitude of fibrinolytic activation. Harenberg et al., (1988) observed a 10%
and 42% increase in fibrinopeptide Bβ 1-42 concentration over baseline after 2 and 4 weeks of
garlic administration, respectively. These results suggest that fibrinolysis increases following
garlic supplementation by enhancement of the activation of plasminogen. Since tPA is the main
activator of plasminogen, this study indirectly supports the hypotheses that garlic either increases
the amount of enzymatically active tPA or acts as a cofactor that increases the affinity between
tPA and plasminogen.
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Table 2.1. The Effects of Garlic Supplementation on Fibrinolysis .
Study
Bordia
et al.
(1975)
Bordia
et al.
(1977)

Problem
Effect of the essential
oils of garlic on FA
and fibrinogen
Effect of essential oil
of garlic on serum FA
in patients with
coronary artery disease

Participants
10 healthy
volunteers
I) 10 healthy
individuals
II) 10 patients
with old
myocardial
infarction
III) 20 patients
with acute
myocardial
infarction

Bordia
et al.
(1978)

Nossel
et al.
(1979
Arora
et al.
(1981)

The effect of essential
oil of garlic on FA in
patients of coronary
artery disease.

Sequence of
fibrinogen proteolysis
Effect of long-term
garlic use on markers
of ischemic heart
disease

I) 20 Healthy
volunteers
II) 20 Patients
with coronary
artery disease
10 female
patients receiving
an abortion
I) 30 individuals
with ischemic
heart disease
II) 20 healthy
volunteers

Design
100 g of butter with 4 slices
of bread plus 50 g of garlic
oil or placebo.
Groups I and II administered
1 g of the essential oil extract
of raw garlic per kg of body
weight per day for 3 mo.
Group III administered 1 g of
the essential oil extract of
raw garlic per kg of body
weight per day for 20 days.

The essential oil extract from
1 g of raw garlic,
administered daily for 3 mo.

Patients received intrauterine
infusion of hypertonic saline
2 x 0.625 mg capsules,
containing the essential oil of
garlic, taken 3 times a day
for 12 wk.

Finding(s)
↑ FA 15% 3 hr after
garlic
administration
I)
↑FA 130% by 3rd
mo
II)
↑FA 83% by 3rd mo
III)
↑ FA 63% above
post-infarction
value after 10 d
↑ FA 95.5% above
post-infarction
value after 20 d
I)
↑ FA 130% by 3rd
mo
II)
↑FA 83% by 3rd mo
Plasmin cleaves
fibrinopeptide Bβ142 from fibrin
↑ FA 52.4% and
52.8% in both
groups at 4th wk.
↑ FA 26.5% and
32.5% in both
groups at 8th wk.

↔ in FA above
resting levels at 12th
wk.
FA= fibrinolytic activity (measured by euglobin clot lysis time), FPB β= Fibrinopeptide Bβ, tPA
ACT= tissue plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, PAI-1=
plasminogen activator inhibitor 1, HUVEC=human umbilical vein endothelial cells
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Table 2.1. The Effects of Garlic Supplementation on Fibrinolysis (Continued).
Study

Problem

Participants

Design

Finding(s)

Chutani &
Bordia
(1981)

Effect of fried versus raw
garlic on FA in man

I) 20 patients with
ischemic heart disease

I) A single dose
of 0.5 g/kg body
weight of raw or
fried garlic.

I)
↑FA 72% by 6
and 12 h with
raw garlic

II) Raw or fried
garlic pods
administered in
doses of 0.5 g/kg
of body weight.

↑ FA 63% and
66% by 6 and
12 h
respectively
with fried garlic

II) 30 patients with
ischemic heart disease

II)
↑ FA 53% at
end of first wk
with raw garlic
↑FA 84.8% by
the end of 1 mo
with raw garlic
↑ FA 40% by
the end of first
wk with fried
garlic

Bordia et
al.
(1982)

The effect of garlic oil on FA
and platelet adhesiveness in
man

I) 20 healthy
volunteers
II) 20 healthy
volunteers

Luley et
al.
(1986)

Harenberg
et al.
(1988)

Effect of dried garlic on FA
and fibrinogen levels

51 hyperlipemic
patients

I) 75 mg butter
plus usual diet for
3 wk
II) 75 mg of
butter plus 0.25
mg/kg body
weight of garlic
oil for 3 wk.
3 x 425 mg
tablets,
containing either
a placebo or dried
garlic
600 mg of dried
garlic pills, 3 x
200 mg daily, for
4 wk.

↑ FA 72% by
the end of 1 mo
with fried garlic
↑ FA 36.3%
with a fatty diet
and garlic oil
by 3 wk.

↔ difference in
FA observed

Effect of dried garlic on
20 out-patients with
↑ FpB β 1-24
blood coagulation,
hyperlipoproteinemia.
10% and 42%
fibrinoylsis, and platelet
after 2nd and 4th
wk,
aggregation in patients with
respectively
hyperlipoproteinemia.
FA= fibrinolytic activity (measured by euglobin clot lysis time), FPB β= Fibrinopeptide Bβ, tPA
ACT= tissue plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, PAI-1=
plasminogen activator inhibitor 1, HUVEC=human umbilical vein endothelial cells
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Table 2.1. The Effects of Garlic Supplementation on Fibrinolysis (Continued).
Study
Kiesewettier
et al.
(1990)

Gadkari et
al.
(1991)

Problem
Effect of garlic on
blood fluidity and FA

Effect of raw garlic on
FA and clotting time.

Participants
10 healthy
volunteers

I) 30 healthy
medical students

Design
100 mg, 300 mg, or
600 mg of
powdered garlic or
placebo
10 g of raw garlic
for 2 mo.

Finding(s)
↑tPA ACT 56.3% in
300 mg trial after 5 h
↑ tPA ACT 51% in
600 mg trial after 5 h
↑FA 21.8% in group I
by 2 mo.

II) 20 healthy
medical students
Jung et al.
(1991)

Effect of garlic powder
on cutaneous
microcirculation

10 healthy
volunteers

Legnani et
al.
(1993)

Effect of dried garlic on
fibrinolysis and platelet
aggregation in healthy
subjects.
Effect of Darlic on
Fibrinolytic and
Fibrinogen in patients
with CAD

10 healthy
volunteers

Bordia et al.
(1998)

Fukao et al.
(2007)

Antithrombotic effects
of odorless garlic
powder in vitro

I)30 patients with
CAD
II)30 patients with
CAD

24-well
multiplates with
seeded human
umbilical vein
endothelial cells
Fibrin film assay

3 x 300 mg of pure
garlic powder
capsules or 3 x 300
mg of placebo
900 mg of dried
garlic powder

↑ tPA ACT 86.1%
after 5 h

I) 2x2 capsules
containing 1 g of
raw garlic

I)
↑ FA 39.4% and
55.1% by 1.5 and 3
mo, respectively

II) 2x2 capsules
containing placebo

HUVECs cultured
with garlic powder
at 37°C for 18 h
Fibrin film plate
with fibrinogen,
thrombin,
plasminogen, tPA
and garlic

↔ difference in tPA
ACT or tPA AG after
2, 4, or 6 h

↔ in fibrinogen levels
II) ↔ in all measures
↔ in release of tPA or
PAI-1 from HUVECs
↑1.8x in tPA ACT on
fibrin plate in the
presence of garlic

↑8.7x increase in
efficacy of enzyme
reaction between tPA
and plasminogen in
the presence of garlic
FA= fibrinolytic activity (measured by euglobin clot lysis time), FPB β= Fibrinopeptide Bβ, tPA
ACT= tissue plasminogen activator activity, tPA AG= tissue plasminogen activator antigen, PAI-1=
plasminogen activator inhibitor 1, HUVEC=human umbilical vein endothelial cells
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The Effects of Acute Exercise on Fibrinolytic Potential
Exercise accelerates fibrinolytic activity (Davis et al., 1979, Wheeler et al., 1986, Drygas
1988, El-Sayed 1990). This acceleration is primarily attributed to elevations in tPA (El-Sayed,
1990). The magnitude of the increase in tPA is dependent upon both the exercise intensity and
duration. A study by Hansen et al. (1990) observed fibrinolytic responses to seven healthy male
volunteers who ran 1.7 km, 4.8 km, and long 10.5 km distances at speeds close to their maximal
capacity. tPA antigen levels rose substantially across all trials, but, the greatest response occurred
in the 10.5 km run, with the 4.8 km run eliciting the second greatest response. A study by Van
Den Burg et al. (1997) also demonstrated the influence of duration. In this study, 20 healthy men
cycled at 70% of VO2max for 25 minutes followed by a graded test to volitional exhaustion.
During the 25 minutes of steady state cycling there was a linear rise in tPA ACT and tPA AG.
However, at the onset of the graded exercise test to maximal exhaustion there was a dramatic
increase in tPA ACT and tPA AG. Although the separate influence of duration on fibrinolytic
activity is important, the primary determent is intensity of exercise. A study by Womack &
colleagues (2006) best demonstrates this principle. In their study they observed that tPA activity
and tPA antigen were significantly higher following 20 minutes of exercise above lactate
threshold (LT) as compared to an isocaloric, longer duration exercise test below LT. Similarly,
Weiss et al. (1998) observed about a 3x larger increase in tPA antigen after a 1 hour run at 83%
VO2max as compared to after a 1 hour run at 68% VO2max.
The mechanisms for the exercise-induced increases in tPA are not completely understood
and numerous factors have been proposed to be responsible for the exercise-induced increases in
tPA. One of the most strongly cited mechanisms is increased adrenergic stimulation. Chandler
and colleagues (1992) observed that the time course and dose response of tPA release was similar
for epinephrine infusion and exercise. However, the absolute rate of increase of tPA versus
epinephrine concentration was 2x as fast during exercise as with infusion. This lead Chandler and
colleagues to attribute approximately 50% of the increase in tPA directly to increased levels of
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epinephrine. Yet if epinephrine only accounts for 50% of the observed increases in tPA, then
there must be at least one other mechanisms to contribute to the remaining 50%. A second
potential mechanism is vasopressin. Vasopressin itself stimulates the fibrinolytic system
(Hariman et al., 1989) and there is a rise in plasma levels of vasopressin during exercise (ElSayed et al., 1990). However, there is no correlation between the exercise induced rise in
vasopressin and the exercise induced rise in fibrinolysis (El-Sayed, 1990). A third commonly
cited mechanism is changes in blood lactate. Wheeler and colleagues (1986) observed a strong
correlation (r=0.81, P< 0.001) between postexercise fibrinolytic activity and postexercise blood
lactate concentrations. However, eight minutes after exercise lactate levels continued to rise but
fibrinolytic activity decreased rapidly. Similarly, Drygas (1988) demonstrated that 60 minutes of
submaximal exercise could increase fibrinolytic activity without changing blood pH. A fourth
potential mechanism may be diminished hepatic clearance. Clearance of tPA is achieved through
the mannose receptor located on hepatic endothelial cells and a low-density lipoprotein receptorrelated protein that is a hepatic receptor for both free tPA and the inactive tPA/PAI-1 complex
(Narita et al., 1995). Blood flow to the liver is reduced during exercise, which in turn decreases
hepatic clearance (Bounameaux et al., 1986; De Boer et al., 1992). This may allow for the
accumulation of tPA in the blood during exercise. Research by Hersch et al. (1987) supports this
theory as they observed elevated tPA levels in patients with decreased clearance due to liver
cirrhosis.
At the termination of exercise tPA levels begin to rapidly decline (Davis et al., 1976).
tPA remains only slightly elevated above base line within 30 minutes after exercise (Hansen et
al., 1990; Van Den Burg et al., 1995). By one hour post-exercise there is no longer any
enhancement of the fibrinolytic system (Paton et al., 2004; Womack et al., 2006). Cooper et al.
(2004) examined the time course changes of tPA after acute maximal exercise in eight healthy
men. Blood samples were collected before exercise and at 1, 2, 4, 5, 6, and 10 minutes post
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exercise. It was observed that plasma tPA activity and antigen reached had significantly declined
within four minutes after exercise.
PAI-1 has been shown to decrease with exercise by some (Paton et al., 2004; Womack et
al., 2006) and to remain unchanged with exercise by others (Hilberg et al., 2003). The response
by PAI-1 has also been shown to vary within the same study depending upon if PAI-1 activity or
PAI-1 antigen was being examined (Hilberg et al. 2003; Womack et al., 2006). This suggests that
PAI-1 is not appreciably altered by exercise. Moreover, statistical power calculations performed
by Cooper & colleagues (2004) reveal that at least 37 participants are necessary to yield a
statistical power of 0.80 for PAI-1 activity. Since most of the studies examining the effect of
exercise on PAI-1 had a participant pool of <37 they lacked sufficient statistical power to
properly examine PAI-1.
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Table 2.2.: The Effects of Acute Exercise on Fibrinolytic Potential
Study
Davis et al.
(1976)

Wheeler et al.
(1986)

Problem
Fibrinolytic
changes during
and after
maximal
exercise

Changes in
hemostatsis
associated with
acute exercise

Participants
10 healthy males

Design
Subjects performed a
graded exercise test to
physical exhaustion

Finding(s)
↑FA ≈175%
immediately postmaximal exercise
↔ FA at
intensities <5060% MHR

19 healthy males

Subjects performed a
branching multistage
treadmill protocol to
maximum

Hersch et al.
(1987)

Pathogenesis of
accelerated
fibrinolysis in
liver cirrhosis

30 liver cirrhosis
patients

Blood samples of 30
liver cirrhosis patients
were taken

Hamouratidis et
al.
(1988)

Effect of
exercise on
plasma
fibrinolytic
activity in
healthy males

30 healthy males

Exercise testing on a
treadmill according to
the Bruce protocol

↑FA
exponentially at
intensities >6070% MHR
↑ FA 505%
postexercise
↓ FA 25% from
postexercise value
8 min postexercise
Postexercise FA
∝ postexercise
blood lactate,
r=0.81
↑tPA AG ≈428%
in patients with
liver cirrhosis

↓ 51% euglobulin
clot lysis time in
healthy men postexercise

FA= fibrinolytic activity, MHR= maximum heart rate, tPA AG= tissue plasminogen activator
antigen
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Table 2.2: Effects of Acute Exercise on Fibrinolytic Potential (Continued).
Study
Drygas
(1988)

Problem
Changes in FA in
response to
moderate,
exhaustive, and
prolonged exercise

Participants
47 healthy men

Design
Subjects
performed
isometric exercise,
18 min of
submaximal
exercise, 60 min of
submaximal
exercise, and
repeated 60 s bouts
of maximal
exercise

Finding(s)
↔ in FA with
isometric exercise
↑ FA 25% after 18
min of submaximal
exercise
↑ FA 58% after 60
min of submaximal
exercise
↑63% after
maximal bouts of
exercise
↔ in pH with
isometric or 60
min of submaximal
exercise

Hariman et al.,
(1989)

Physiological
concentrations of
vasopressin on the
fibrinolytic system

9 male volunteers

Infusion of saline
for 30 min
followed by
infusion with
vasopressin for 1
hour

↓ pH 0.5% and 2%
with 18 min of
submaximal
exercise and
repeated maximal
exercise,
respectively
↑ tPA ACT ≈28x
60 min postinfusion

↓ PAI-1 ACT
≈19% 60 min postinfusion
FA= fibrinolytic activity, tPA ACT= tissue-type plasminogen activator activity, PAI-1
ACT=plasminogen activator inhibitor activity
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Table 2.2. Effects of Acute Exercise on Fibrinolytic Potential (Continued).
Study
ElSayed
(1990)

Problem
Exercise intensity
related responses of
fibrinolysis and
vasopressin

Participants
16 normal
healthy subjects

Design
Subjects cycled at 40%,
70% and 100% of
VO2max

Finding(s)
No correlation between
exercise-induced
changes in FA and
vasopressin
↑ in FA in response to
exercise is directly
related to fractional
workload (%VO2max)

Hansen
et al.
(1990)

De
Boer et
al.
(1992)

Procoagulant and
fibrinolytic activities
in circulation after
strenuous physical
exercise

Liver Blood Flow as a
Determinant of tPA
Clearance

7 healthy
recreationally
active men

6 healthy males
8 male Wistar
rats

Subjects participated in
short (1.7km), middle (4.8
Km) and long (10.5 km)
runs at a speed close to
their maximal capacity

Subjects performed a
submaximal exercise test
while receiving an
infusion of ICG and rtPA
Rat liver perfused through
portal vein with rtPA at
different flow rates

↑ in exercise-related
FA is mainly due to
elevated tPA levels
↑≈ 300%, 200%, 180%
in tPA AG at long,
middle, and short
distances respectively
tPA AG ↓ to baseline
by 30 min postexercise
↑rTPA ACT and AG
119% and 91%
respectively during
exercise
↑ICG 133% during
exercise
↓liver blood flow 53%
during exercise
Live blood flow
returned to normal 25
min post-exercise

Halving or doubling
flow rate of perfused
rate liver causes
proportional changes
in rtPA clearance
FA= fibrinolytic activity, tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue
plasminogen activator antigen, PAI-1 ACT=plasminogen activator inhibitor activity, ICG=
tricarboycyanine dye indocyanine green,
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Table 2.2. Effects of Acute Exercise on Fibrinolytic Potential (Continued).
Study
Chandler et al.
(1992)

Problem
Fibrinolytic
response during
exercise and
epinephrine
infusion in the
same subjects

Participants
14 healthy men

Design
Participants were
studied during
epinephrine infusion
and graded supine
bicycle exercise to
exhaustion.

Finding(s)
↑388% tPA ACT
at point of
exhaustion over
baseline
↑PAI-1 ACT 24%
at point of
exhaustion over
baseline
↑ 218% tPA
ACT at maximal
epinephrine
infusion rate over
baseline
↔ in PAI-1 or
tPA/PAI-1
complex during
infusion

Linear
relationship
between tPA and
epinephrine levels
observed
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator
antigen, PAI-1 ACT=plasminogen activator inhibitor activity
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Table 2.2. Effects of Acute Exercise on Fibrinolytic Potential (Continued).
Study
Szymanski &
Pate
(1994)

Problem
Fibrinolytic
responses to
moderate
exercise in
physically active
and inactive men

Participants
I) 14 inactive men
II) 12 active men

Design
Two 30 minute
submaximal exercise
sessions at 50% of
VO2max

Finding(s)
↑ tPA ACT ≈71%
with evening
exercise in active
group
↑tPA ACT ≈28%
with morning
exercise in active
group

Fibrinolytic
responses during
morning and
evening exercise

↑ tPA ACT ≈25%
with evening
exercise in
inactive group
↑tPA ACT ≈8%
with morning
exercise in
inactive group

Van Den Burg
et al.
(1995)

Haemostatic
changes
following
strenuous
physical exercise

29 healthy
sedentary men

Exercise test consisted
of 4 phases on a cycle
ergometer: 1) 25
minutes of cycling at
70% VO2max 2) graded
cycling to VO2max,
3)10 min of active
recover, 4) 15 minutes
of passive recovery

↔ in PAI-1 ACT
with exercise in
either group at
either time point
↑183% tPA AG at
maximal exercise
↑tPA ACT 892%
at maximal
exercise
↓tPA ACT 61%
from maximal
exercise value by
25 min of
recovery
↓ tPA ACT 42%
from maximal
exercise value by
25 min of
recovery

Coagulant and
fibrinolytic
activity during
submaximal
exercise are = up
to 70% VO2max
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen,
PAI-1 ACT=plasminogen activator inhibitor activity
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Table 2.2. The Effects of Acute Exercise on Fibrinolytic Potential (Continued).
Study
Szymanski et al.
(1996)

Problem
Factors affecting
fibrinolytic
potential

Participants
46 healthy white
men

Design
Maximal graded
exercise tests on a
treadmill

Van Den Burg
et al.
(1997)

Effect of
endurance
training on
seasonal
fluctuations on
coagulation and
fibrinolysis

20 healthy
sedentary men

Exercise tests were
performed in 4 phases
on a cycle ergometer: 1)
25 minutes of cycling at
70% VO2max, 2)
graded cycling to
VO2max, 3)10 min of
active recovery, 4 15
minutes of passive
recovery.

Coagulation and
fibrinolysis after
moderate and
very heavy
exercise

12 young men

Weiss et al.
(1998)

Two treadmill tests at
68% and 83% VO2max
for 1 h

Finding(s)
↑217% in tPA
ACT, ↓31% PAI1 ACT following
maximal exercise
tPA ACT and tPA
AG ↑ linearly
with time during
submaximal
exercise
tPA ACT and tPA
AG↑
exponentially
during graded
exercise tests
↑tPA AG ≈300%
and ≈380% after
30 min and 60
min of running at
83% VO2max
↑tPA AG 100%
and 160% after 30
min and 60 min
of running at 68%
VO2max
↓ tPA AG to base
line 1 h post-83%
VO2max run
Fibrinolytic
system ↑to a
higher degree
during heavy
exercise than the
coagulant system

Fibrinolytic
potential ↓ at
faster rate than
coagulation
potential postexercise
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen,
PAI-1 ACT=plasminogen activator inhibitor
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Table 2.2. The Effects of Acute Exercise on Fibrinolytic Potential (Continued).
Study
Hedge et al.
(2000)

Hilberg et al.
(2003)

Hilberg et al.
(2003)

Problem
Changes in
clotting and
fibrinolytic
activity during
the 1 h after a
submaximal run

Participants
10 healthy males

Blood
coagulation and
fibrinolysis after
extreme shortterm exercise

15 healthy trained
males

Blood
coagulation and
fibrinolysis after
long duration
treadmill
exercise
controlled by
anaerobic
threshold

16 healthy males

Design
Subjects completed two
treadmill tests at either
70-75% VO2max or at
1.2 mph for 30 minutes
each.

Three maximal cycle
ergometer tests with
duration of 15, 45, and
90s and a control day
without an exercise

Treadmill ergometer
test at intensity of 90%
of individual anaerobic
threshold lasting 60-120
min

Finding(s)
↑200% tPA ACT
after 30 min of
running
↓ tPA ACT 33%,
44%, and 49% 20
min, 40 min, and
60 min postexercise
↑ tPA AG 83%,
149%, and 293%
after 15s, 45s, and
90s respectively
Changes in tPA
AG returned to
baseline 1 h postexercise
↑ tPA ACT 32%
post exercise over
baseline
↓ tPA ACT to
baseline value 2 h
post-exercise
↑tPA AG 737%
immediately post
exercise
↓ tPA AG 82% 2
h post-exercise
from initial postexercise value
↓PAI-1 ACT 69%
post-exercise.

↑ PAI-1 AG 26%
2 h post-exercise
over post-exercise
value
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen,
PAI-1 ACT=plasminogen activator inhibitor
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Table 2.2.The Effect of Acute Exercise on Fibrinolytic Potential (Continued).
Study

Problem

Participants

Design

Finding(s)

Womack et al.
(2003)

Coagulation and
Fibrinolytic
Response to
Manual vs
Automated
Snow Removal

13 health male
subjects

Subjects performed a
maximal ramped
treadmill test, shoved a
driveway clear of snow,
and removed snow from
a driveway with an
automated snow
thrower

↑tPA AG 227%
immediately postexercise with
treadmill test

Temporal
changers in tPA
and PAI-1 after
maximal
exercise

8 healthy males

Cooper et al.
(2004)

Paton et al.
(2004)

Changes in von
Willebrand
factor and
fibrinolysis
following a postexercise cooldown

Subjects performed a
graded exercise test to
volitional exhaustion on
a treadmill

↓PAI-1 31%
immediately postexercise with
treadmill test
↑ tPA ACT 19x
from baseline to
post-exercise
↑tPA AG 5x from
baseline to postexercise

10 healthy males

Subjects performed two
maximal treadmill tests.
Each test was followed
by either an active cool
down or a passive cool
down

↓PAI -1 ACT
≈55% from
baseline to postexercise
↑ tPA ACT and
tPA AG ≈15x and
≈4x respectively

Fibrinolytic
potential returned
to baseline 1 h
post exercise
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen,
PAI-1 ACT=plasminogen activator inhibitor

25

Table 2.2.The Effect of Acute Exercise on Fibrinolytic Potential (Continued).
Study
Womack et al.
(2006)

Problem
Changes in
fibrinolysis
following
exercise above
and below
lactate threshold

Participants
15 healthy males

Design
Subjects performed
cycle ergometry tests
>LT threshold and
equicaloric cycle
ergometry <LT

Finding(s)
↑tPA ACT 145%
in the >LT trial
↑tPA AG 71%
and 22% in the
>LT and <LT
trials
Post-exercise tPA
AG 37% higher
in >LT trial
↓PAI-1 ACT
33% and 13 % in
both the >LT and
<LT trials

↔ changes in
tPA or PAI-1
levels 1 h postexercise
tPA ACT= tissue-type plasminogen activator activity, tPA AG= tissue plasminogen activator antigen,
PAI-1 ACT=plasminogen activator inhibitor, LT= lactate threshold
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The Effects of Acute Exercise on Coagulation Potential
Exercise induces a hypercoagulant state (Davis et al., 1976; Wheeler et al., 1986; ElSayed, 1993; Hedge et al., 2001). As with fibrinolytic activity, markers of coagulation rise
substantially after the onset of exercise (Davis et al., 1976; Wheeler et al., 1986; Hansen et al.,
1990; Van Den Burg et al., 1995; Van Den Burg et al., 1997). This rise in coagulation activity
parallels the aforementioned rise in fibrinolytic potential up to 70% VO2max (Van Den Burg et
al., 1995). At higher intensities there is an even more pronounced increase in fibrinolytic potential
that exceeds the increase in coagulant activity (Van Den Burg et al., 1995; Weiss et al., 1998).
This suggests a reduced thrombotic tendency at these higher intensities.
Post-exercise there is a marked difference in the coagulant response as compared to the
fibrinolytic response. As mentioned in the previous section, there is an immediate decrease in
firbinolysis post-exercise with values rapidly returning to baseline (Weiss et al., 1998). However,
with coagulant activity, markers either persistently rise (Wheeler et al., 1986, Weiss et al., 1997;
Van Den Burg et al., 1997; Hilberg et al., 2003), remain elevated (Hedge et al., 2000; Paton et al.,
2004), or decline slowly with levels remaining significantly elevated above baseline up to 10
hours later (Hansen et al., 1990).
The mechanisms responsible for the exercise-induced increase in coagulant activity are
not fully understood. This is inherently due to the intricate nature of the coagulation cascade
itself. However, some mechanisms may be described, albeit not fully. The increase in clotting
activity, as measured by a fall in the activated partial thromboplastin time (aPPT), can be
attributed to an increase in FVIII activity. Hedge et al. (2000) examined the clotting activity
during the hour after a submaximal run at 70-75% VO2max in 10 healthy men and observed that
aPPT decreased by approximately 2 seconds and remained shortened during the entire 1 hour
recovery period. They also observed that this shortening in aPTT was significantly correlated (r=0.7) to increases in FVIII activity. Yet, the mechanism(s) for the increased FVIII activity are not
fully understood. Since FVIII is composed to two proteins, factor VIII:C and Von Willebrand
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Factor (vWF), vWF can be used to elucidate changes in coagulation potential as well. Von Kanel
et al. (2003) demonstrated that beta-adrenergic stimulation and blockade respectively increases
and inhibits the release of vWF from endothelial cells. Since exercise produces substantial
elevations in epinephrine (Chandler et al., 1992), perhaps increased concentrations of
catecholamines is the mechanism for enhanced coagulant activity. However, this is unlikely to be
a lone mechanism as catecholamines do not display a continual increase post-exercise (Dimsdale
et al., 1984). Another proposed mechanism is reduced hepatic blood flow. FVIII is cleared at the
liver by a low-density lipoprotein-related receptor (Saenko et al., 1999). Paton et al. (2004)
examined changes in vWF following a post-exercise cool-down in 10 healthy men. They
observed that an active cool-down resulted in reduced levels of vWF post-cool down and 1 hour
post-exercise. Since active cool-downs are used to prevent venous pooling and improve venous
returns, this may suggest that hepatic clearance can play a role. However, hepatic blood flow
returns to normal levels rapidly post-exercise (De Boer et al., 1992). Therefore, it seems unlikely
that reduced hepatic clearance is a primary cause of the persistent coagulant activity postexercise. Additional proposed hypotheses include the neogenesis of FVIII from the vascular
endothelium (El-Sayed, 1993), increased thrombin activation (El-Sayed, 1993), and lactic
acidosis (Crowell & Houston, 1961). Clearly future research is needed to elucidate the exact
mechanisms of the exercise-induced enhancement in coagulant activity.
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Table 2.3. The Effects of Acute Exercise on Coagulation Potential.
Study
Crowell &
Houston
(1961)

Problem
Effect of acidity
on blood
coagulation

Participants
15 dogs

Davis et al.
(1976)

Fibrinolytic
changes during
and after
maximal
exercise

10 healthy males

Dimsdale et al.
(1984)

Wheeler et al.
(1986)

Changes in
catecholamines
postexercise

Pyhsiological
changes in
hemostasis
associated with
acute exercises

Design
Samples of heparinized
blood had their pH
altered, ranging from
6.0-7.4, via the addition
of lactic acid to the
sample
Subjects performed a
graded exercise test to
physical exhaustion

Finding(s)
Lowering the pH
of heparinized
blood to ≈6.7
reduced clotting
time
↔ FVIII at
intensities <6070% MHR
↑FVIII
exponentially at
intensities >70%
MHR

10 healthy males

19 health male
subjects

Subjects performed a
graded exercise test to
exhaustion

Subjects performed a
branching multistage
treadmill protocol to
maximum

Peak ↑FVIII,
125%, occurred 5
min post-exercise
↑ NEPI and EPI
≈880% and
≈241% 3 minutes
post-exercise,
respectively
↓NEPI and EPI
≈48% ≈36% from
3 min value by 6
min
↑FVIII activity
≈180% postexercise

↑FVIII activity
≈300% 8 min
post-exercise as
compared
baseline value
F VIII= Factor VIII, FVIII= Factor VIII, NEPI= norepinephrine, EPI= epinephrine
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Table 2.3 The Effect s of Acute Exercise on Coagulation Potential (Continued)
Study
Hansen
et al.
(1990)

El-Sayed
(1993)

Van Den
Burg et
al.
(1995)

Problem
Procoagulant and
fibrinolytic
activities in
circulation after
strenuous physical
exercise

Hemostatic
responses after
resistance exercise

Haemostatic
changes following
strenuous physical
exercise

Participants
7 healthy
recreationally
active men

Seven healthy
subjects

29 healthy
sedentary men

Design
Subjects participated in short
(1.7km), middle (4.8 Km)
and long (10.5 km) runs at a
speed close to their maximal
capacity

Subjects performed 3
exercise sessions: low
volume resistance exercises
at 90-100% 1RM, high
volume resistance exercises
at 70-80% 1RM, or no
exercise control
Exercise test consisted of 4
phases on a cycle ergometer:
1) 25 minutes of cycling at
70% VO2max 2) graded
cycling to VO2max, 3)10
min of active recover, 4) 15
minutes of passive recovery

Finding(s)
↑vWF 194%, 95.9%,
95.9% in short,
middle, and long
runs, respectively,
immediately postexercise
vWF remained
≈30%, 60%, and 80%
elevated in short,
middle, and long runs
10 h after exercise
↑ FVIII 100% post
low volume
resistance exercise
↑FVIII 160% post
high volume
resistance exercise
Coagulant and
fibrinolytic activity
during submaximal
exercise are = up to
70% VO2max
↑ FVIII, FXII, FIX,
and FVII 80%, 10%,
17%, and 4% over
baseline at maximal
exercise
↑Factor VIII 148%
over baseline 25 min
following maximal
exercise
↓aPTT 15% over
baseline at maximal
exercise

↓aPTT16.3% over
baseline 25 min
following maximal
exercise
vWF=von Willebrand factor, aPTT= Activated partial thromboplastin time, F VIII= Factor
VIIIFVIII= Factor VIII, FXII= Factor XII, FIX= Factor IX, and, FVII= Factor VII,
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Table 2.3 The Effects of Acute Exercise on Coagulation Potential (Continued)
Study
Van Den Burg
et al.
(1997)

Problem
Effect of
endurance
training on
seasonal
fluctuations on
coagulation and
fibrinolysis

Participants
20 healthy
sedentary men

Design
Exercise test consisted of
4 phases on a cycle
ergometer: 1) 25 minutes
of cycling at 70%
VO2max 2) graded
cycling to VO2max, 3)10
min of active recover, 4)
15 minutes of passive
recover

Finding(s)
↑ FVIII ≈100%
and ≈126%
immediately
following
maximal exercise
and 25 min
following
maximal exercise,
respectively
↓aPTT ≈14% and
remained ↓to this
extent 25 min
later

F VIII= Factor VIII, aPTT= Activated partial thromboplastin time
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Table 2.3. The Effects of Acute Exercise on Coagulation Potential (Continued).
Study
Weiss et al.
(1998)

Problem
Coagulation and
fibrinolysis after
moderate and very
heavy exercise

Participants
12 young men

Design
Two treadmill tests
at 68% and 83%
VO2max for 1 h

Finding(s)
↑FPA ≈100%, and
≈155% over
baseline after 30
and
60 min of running
at 83% VO2max
run
↑FPA ≈144% over
baseline 1 h post83% VO2max run
↑TAT ≈87% over
baseline after 60
min of running at
83% VO2max
↑TAT 47% over
baseline 1 h post83% VO2max run
↓aPTT 8% and
13% from baseline
30 and 60 min
post-83% VO2max
run
↓aPTT 11% from
baseline 1 h post83% VO2max run
Fibrinolytic system
↑ to a higher degree
during heavy
exercise than the
coagulant system

Saenko et al.,
(1999)

Catabolism of
factor VIII by LPR

Cultured mouse
embryonic
fibroblasts

Cell-mediate ligand
internalization and
degradation assays

Fibrinolytic
potential ↓ at faster
rate than
coagulation
potential postexercise period
FVIII specifically
binds to LPR

LPR mediates
internalization and
degradation of
FVIII
aPTT= Activated partial thromboplastin time, TAT= Thrombin Antithrombin III Complex, FPA=
Fibrinopeptide A, LPR= Low density lipoprotein receptor-related protein

Table 2.3. The Effects of Acute Exercise on Coagulation Potential (Continued).
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Table 2.3. The Effects of Acute Exercise on Coagulation Potential (Continued).
Study
Hedge et al.
(2000)

Von Kanel et al.
(2000)

Hilberg et al.
(2003)

Problem
Changes in clotting
and fibrinolytic
activity during the
1 h after a
submaximal run

Participants
10 healthy males

Design
Subjects
completed two
treadmill tests at
either 70-75%
VO2max or at 1.2
mph for 30
minutes each.

Finding(s)
↑ FVIII ≈40% after
30 min of running
FVIII remained
≈40% elevated 1 h
post-exercise
↓8% in aPTT
immediately after
submaximal run
showed significant
negative
correlation (r=-0.7)
with ↑ in FVIII
Isoproternol
infusion led to ↑ in
plasma vWF
across all subjects.

Effects of
nonspecific βadrenergic
stimulation and
blockade on blood
coagulation in
hypertension

I) 15 hypertensive
subjects and 21
normotensive
subjects

I) Subjects
received
isoproternol
infusion

II) 13 member
subgroup (3
hypertensives)

II) Subjects were
studied twice, once
after 5 days of
placebo treat and
once after 5 days
of 100 mg/day of
propranolol

Propranolol
completely
abolished the ↑ in
wVF elicited by
isoproternol

Blood coagulation
and fibrinolysis
after extreme
short-term exercise

15 healthy trained
males

Three maximal
cycle ergometer
tests with duration
of 15, 45, and 90s
and a control day
without an exercise

↓ aPTT 10%, 17%,
and 20% after15s,
45s, and 90s.
Changes in aPTT
not fully reversed
after 1 h
↑ TAT 53%
immediately postexercise
Remained elevated
2 h post-exercise

↑F1+2 34%
immediately post
exercise
vWF=von Willebrand factor, aPTT= Activated partial thromboplastin time, F1+2= Prothrombin
Fragment, FVIII= Factor VIII,
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Table 2.3. The Effects of Acute Exercise on Coagulation Potential (Continued).
Study
Hilberg et al.
(2003)

Problem
Blood
coagulation and
fibrinolysis after
long duration
treadmill exercise
controlled by
anaerobic
threshold

Participants
16 healthy males

Design
Treadmill ergometer test
at intensity of 90% of
individual anaerobic
threshold lasting 60-120
min

Finding(s)
↓aPTT 14% and
11%
immediately postexercise and 2 h
post-exercise,
respectively, as
compared to
baseline
↑ TAT 53%
immediately postexercise

Paton et al.
(2004)

Changes in von
Willebrand factor
and fibrinolysis
following a postexercise cooldown

10 healthy males

Womack et al.
(2003)

Coagulation and
Fibrinolytic
Response to
Manual vs
Automated Snow
Removal

13 health male
subjects

Subjects performed two
maximal treadmill tests.
Each test was followed
by either an active cool
down or a passive cool
down

↑F1+2 34% and
16%
immediately post
exercise and 2 h
post-exercise
respectively
↑vWF: ≈ 120%
and ≈88% postcooldown and 1 h
post-exercise,
respectively, as
compared to
baseline
↑vWF 76%
immediately postexercise with
treadmill test

Subjects performed a
maximal ramped
treadmill test, shoved a
driveway clear of snow,
and removed snow from
a driveway with an
automated snow thrower
vWF=von Willebrand factor, aPTT= Activated partial thromboplastin time, F1+2= Prothrombin
Fragment, TAT= Thrombin Antithrombin III Complex
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Methodological Considerations for Fibrinolytic Research
Participants are an important methodological consideration for conducting research
involving fibrinolysis. Research has shown that activation of the fibrinolytic system varies across
the menstrual cycle (Cederblad et al., 1977; Giardina et al., 2004). Therefore, one either needs to
avoid using female participants or control for differences in the menstrual cycle status. The
physical activity status of the participants also needs to be taken under consideration. Physically
active men tend to have lower resting PAI-1 values and slightly higher tPA activity values postexercise as compared to physically inactive men (Symanski & Pate, 1994).
A second point to consider is time of day. There are significant circadian variations in the
fibrinolytic system (Angleton et al., 1988). PAI-1 activity and tPA antigen are highest in the
morning compared to the evening. In contrast, tPA activity is lowest in the morning and highest
in the evening. The fibrinolytic response to physical activity is also influenced by time of day as
physical activity in the evening elicits a substantially greater fibrinolytic response than physical
activity in the morning (Symanski & Pate, 1994). Therefore, to avoid time day confounding the
data, it is necessary have each of a participant’s treatment trials occur at the same time of day.
Posture must also be standardized when conducting experiments involving fibrinolytic
potential. Winther & colleagues (1992) examined the effects of posture on fibrinolytic potential in
12 healthy men. Participants went from the supine to upright posture, the upright to supine
posture, and the supine to upright posture across the time course of a morning. Participants held
the remained in the new posture after each switch for 90 minutes. Significant variations in tPA
antigen levels were noticed 10 minutes following the supine to upright and upright to supine
posture shifts. No statistical differences were seen in either postural shift after the new posture
had been assumed for the next time point (90 minutes). This suggests that when evaluating tPA
antigen levels, it is necessary to control for postural effects by standardizing pre-trial positions for
a minimum of greater than 10 minutes.
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The timing of post-exercise blood sampling is also an important methodological
consideration as the half-life of tPA is approximately 3 minutes (Korninger et al., 1981; Nilsson
et al., 1984) and fibrinolytic activity declines post-exercise have been noted in as little as 5
minutes (Davis et al., 1976). A study by Cooper et al. (2004) examined the temporal changes in
tPA and PAI-1 after maximal exercise. tPA activity did not change from 1 to 2 minutes postexercise but decreased significantly by 4 minutes post-exercise. They also observed PAI-1
decrease from pre to post-exercise but PAI-1 values did not change during 10 minutes postexercise. This suggests that to accurately assess the tPA response to acute exercise, blood samples
need to be collected within 2 minutes after the cessation of exercise.
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Table 2.4. Methodological Considerations for Fibrinolytic Research
Study
Davis et al.
(1976)

Cederblad et al.
(1977)

Korninger et al.
(1981)

Nilsson et al.
(1984)

Angleton et al.
(1989)

Problem
Fibrinolytic
changes during
and after maximal
exercise
Variations in
blood coagulation
and fibrinolysis
across the
menstrual cycle

Turnover of
Human tPA

In vivo
metabolism of
human tPA

Diurnal variation
on fibrinolytic
potential

Participants
10 healthy males

30 normal women

7 New Zealand
white rabbits

2 healthy males

I) 33 healthy men
II) 15 patients with
previous MI or
unstable angina

Design
Subjects performed
a graded exercise
test to physical
exhaustion
Blood samples
collected across the
menstrual cycle

Injected tPA from
purified cell culture
fluids radiolabelled
with 125I

Injected tPA from
purified cell culture
fluids radiolabelled
with 125I

Resting blood
samples were taken
in the morning and
evening in groups I
and II.

Finding(s)
↓FA ≈15% from
post-exercise
maximum by 5
min post-exercise
FA is greatest
during
menstruation and
luteal phase
FA is the smallest
during the
follicular phase
and ovulatory
phase
Half-life of
injected tPA is ≈23 min
tPA is mainly
cleared by the liver
Half-life of
injected tPA is ≈34 min
tPA is mainly
cleared by the liver
↓PAI-1 ACT 44%
and 48% in groups
I and II between
morning and
evening
↑ tPA ACT 80%
and 113% in
groups I and II
between morning
and evening

↓tPA AG 15% and
23% in groups I
and II between
morning and
evening
FA= Fibrinolytic Activity, tPA ACT= Tissue Plasminogen Activator Activity, tPA AG= Tissue
Plasminogen Activator Antigen, PAI-1 ACT= Plasminogen Activator Inhibitor 1 Activity, PAI-1
AG= Plasminogen Activator Inhibitor Antigen, FA= Fibrinolytic Activity
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Table 2.4. Methodological Considerations for Fibrinolytic Research (Continued).
Study
Problem
Participants
Design
Finding(s)
Winther et al.
(1992)

Szymanski & Pate
(1994)

Effects of upright
posture on
fibrinolytic
activity

Fibrinolytic
responses to
moderate exercise
in physically
active and inactive
men
Fibrinolytic
responses during
morning and
evening exercise

12 male volunteers

I) 14 inactive men
II) 12 active men

Subjects assume
the upright posture
for 90 min, lay
supine for 45 min,
and then returned
to upright posture
for 90 min.

Two 30 minute
submaximal
exercise sessions at
50% of VO2max

↑tPA AG 64% by
moving from a
supine posture to
an upright posture
↓tPA AG 17% by
moving from
upright to supine
posture
↑FA 27% in
upright posture
versus supine
posture
↑ tPA ACT ≈71%
with evening
exercise in active
group
↑tPA ACT ≈28%
with morning
exercise in active
group
↑ tPA ACT ≈25%
with evening
exercise in inactive
group
↑tPA ACT ≈8%
with morning
exercise in inactive
group

↔ in PAI-1 ACT
with exercise in
either group at
either time point
tPA ACT= Tissue Plasminogen Activator Activity, tPA AG= Tissue Plasminogen Activator Antigen,
PAI-1 ACT= Plasminogen Activator Inhibitor 1 Activity, PAI-1 AG= Plasminogen Activator
Inhibitor Antigen, FA= Fibrinolytic Activity
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Table 2.4. Methodological Considerations for Fibrinolytic Research (Continued).
Study
Cooper et al.
(2004)

Problem
Temporal
changers in tPA
and PAI-1 after
maximal exercise

Participants
8 healthy males

Design
Subjects performed
a graded exercise
test using a
treadmill ramped
protocol until
volitional
exhaustion

Finding(s)
↑tPA ACT 19x
from pre-exercise
to 1 min postexercise period
↔ tPA ACT from
1 to 2 min postexercise
tPA ACT↓
significantly by 4th
min post-exercise
as compared to 1st
min post-exercise
value
↓PAI-1 ACT 56%
from pre-exercise
to 1 min postexercise.

Giardina et al.
(2004)

Variability of
Hemostatic and
Fibrinolytic
Factors in Young
Women

20 pre-menopausal
women

Underwent blood
testing across the
menstrual cycle

↔ changes
observed in PAI-1
ACT from 1 min
post-exercise to
any other postexercise time point
Difference in
amount of
estradiol between
follicular and
luteal phase mean
∆= 30 pg/mL
Change in
estradiol
associated with
change in PAI-1,
mean ∆= 14
ng/mL
Change in
estradiol
associated with
change in DDimer, mean ∆=57
ng/mL

tPA ACT= Tissue Plasminogen Activator Activity, tPA AG= Tissue Plasminogen Activator Antigen, PAI-1
ACT= Plasminogen Activator Inhibitor 1 Activity, PAI-1 AG= Plasminogen Activator Inhibitor Antigen, FA=
Fibrinolytic Activity

Chapter Three
Methods
Participants
Twenty trained males, between the ages of 18-25, from the James Madison University
community and the surrounding Harrisonburg area, agreed to take part in this study. Two of
these subjects dropped out of the study. The remaining 18 completed both treatment trials.
Subject characteristics are summarized in table 3.1. Exclusion criteria included: any known
cardiovascular, pulmonary, or metabolic disease; current tobacco use; current use of any
medication known to influence fibrinolysis; infection; fever, or illness within 2 weeks prior to
testing; garlic or flour allergy; and any other medical condition that could compromise safety.
The questionnaire used to determine this information can be found in Appendix A. Participants
were provided with written and verbal information about the experimental procedures, including
potential risks, prior to completing the informed consent form (Appendix B). All procedures were
approved by the James Madison University Committee on Research Involving Human Subjects
prior to testing.
Table 3.1: Subject Characteristics
Age (yrs)
Height (cm)

Weight (kg)

Mean ± SD

75.5 ± 9.6

20.9 ± 2.2

178 ± 7.7

BMI
23.8 ± 2.3

Determination of Training Status
The short-form International Physical Activity Questionnaire (IPAC) was administered
prior to testing (Appendix C). The IPAQ short form has acceptable reliability and criterion
validity in men (Kurtze et al., 2008). The criterion for being considered trained in the current
study was: A) 3 or more days of vigorous-intensity activity of at least 20 min per day or B) 7 or
more days of any combination of walking, moderate-intensity or vigorous-intensity activities
achieving a minimum total physical activity of at least 3000 MET-min*wk-1.
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Supplementation
Participants were given a packet containing either the placebo treatment (PT), which
consisted of three gel capsules containing flour, or the garlic treatment (GT), which consisted of
three 300 mg capsules of Kyolic Brand powdered aged garlic extract (Mission Viejo, CA). These
treatment packets were administered in a randomized, double-blind, cross-over fashion to ensure
that an equal number of participants performed the placebo treatment and the garlic treatment
first. Participants were instructed to ingest all of the tablets with a glass of water three hours prior
to testing. Participants were also required to fast for 12 hours and abstain from alcohol
consumption for 24 hours prior to testing. Adherence to the dietary restrictions was confirmed by
a 24 hour food recall questionnaire administered prior to testing. All tests were performed before
10AM to minimize the effect of diurnal variations (Angleton et al., 1989) and each participant
was tested at the same time of day for both trials.
Exercise Tests
Treatment Trials
Participants reported to the Human Performance Laboratory on the campus of James
Madison University’s in the morning after having supplemented with 900 mg of powdered garlic
or a placebo. To control for any postural effects on fibrinolysis, participants assumed a semirecumbent position for 20 min prior to obtaining the baseline blood sample (Winther et al., 1992).
Participants then completed a treadmill graded exercise test to volitional fatigue. Post-exercise
blood samples were taken within two minutes of the cessation of exercise to avoid an immediate
decline in tPA (Cooper et al, 2004). The final blood samples were taken one hour after exercise.
Participants repeated the protocol with the other treatment two weeks later.
Maximal Exercise Test
Each participant performed a graded treadmill test on a Stairmaster Clubtrack 612
treadmill (Kirkland, WA). The test began at an initial speed of 2.5 mph. Speed was then increased
at a rate of 0.5 mph min-1 until 6.0 mph was reached. At this point, the treadmill speed remained
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constant while the elevation increased at a rate of 3.0% * min-1 until 15.0% grade was reach.
Speed was then increased once again at a rate of 0.5 mph min-1 until volitional exhaustion. VO2
was continuously monitored with a Sensormedics Spectra metabolic cart (Yorba Linda, CA). This
protocol has been previously shown to elicit a large fibrinolytic response (Paton et al., 2004;
Cooper et al., 2004).
Blood Sampling
For each blood sample 5 ml of venous blood was collected in a tube treated with acidified
citrate (Biopool International; Ventura, Calif) and an additional 5 ml of blood was collected in an
EDTA tube. Whole blood collected in EDTA was analyzed for hematocrit using the
microhematocrit method. The remainder of the EDTA sample and the blood collected in an
acidified citrate tube were spun in a refrigerated centrifuge (4°C) at 10,000 rpm for 20 min to
obtain platelet-poor plasma. Plasma was alliquoted and stored at -80°C until assayed. Fibrinolytic
potential was determined by assaying for tPA activity, tPA antigen, and PAI-1 activity. tPA
activity was determined by using an amidolytic activity assay (Biopool International; Ventura,
Calif). tPA antigen and PAI-1 activity were determined using an enzyme linked immunosorbancy
assay (ELISA) (American Diagnostica, Greenwich, Conn and Diapharma respectively). All
values for tPA and PAI-1 were corrected for plasma volume changes (Van Beaumont et al.,
1972).
Dietary and Exercise Controls
Throughout the duration of the study participants were instructed to: 1) choose a standard
“self-selected” meal plan for the 24 hours preceding the two treatment trials, 2) consume the last
meal of the day no later than 12-hours prior to the treatment trials, 3) avoid consumption of
alcohol 24-hours prior to each treatment trial, and 4) avoid exercise immediately prior to each
treatment trial. Compliance with the dietary restrictions was confirmed via the administration of a
24 hour food re-call questionnaire prior to teach treatment trial. Compliance was defined as a
75% match between the garlic and the placebo trials’ food logs. Twelve of the 18 participants met
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this criterion. However, the participants who did not meet this criterion did not report eating
garlic the day prior to testing. Compliance to the exercise restrictions was confirmed verbally
before each treatment trial. Participants were allowed to drink water ad libitum throughout the
duration of the study.
Statistical Analysis
A two-factor (treatment and time) repeated measures analysis of variance (ANOVA) was
used to assess changes in tPA activity, tPA antigen, and PAI-1 activity. The two within-subject
factors were treatment condition (placebo trial (PT) and garlic trial (GT)) and time (pre-exercise,
post-exercise, and 1 hour post-exercise). Post hoc tests were performed using two-tailed t-tests
with a bonferroni correction factor. Differences in participant weight, resting hematocrit,
VO2max, respiratory exchange ratio (RER), and treadmill time between the two treatment
conditions were assessed via two-tailed paired t-tests. An alpha level of P<0.05 was set as the a
priori level of statistical significance.

Chapter Four
Results
Exercise Performance
No significant difference (P > 0.05) was found between the two treatment conditions for
weight [PT = 75.5 ± 9.6 kg, GT = 75.4 ± 9.8 kg], resting hematocrit [PT = 42.4 ± 10.9%, GT =
44.9 ± 2.6%] or treadmill time [PT = 14.23 ± 1.3 min, GT = 14.15 ± 1.4 min]. One participant’s
nose clip fell off during a trial and was therefore excluded from the VO2max analysis. A
significant difference (P < 0.05) was found between the two treatment conditions for absolute
VO2max [PT = 4.48 ± 0.47 L min-1, GT = 4.61 ± 0.59 L min-1] and relative VO2max [PT = 59.8 ±
6.7 ml kg-1 min-1, GT = 61.4 ± 6.6 ml kg-1 min-1]. No significant difference (P > 0.05) was found
between the two treatment conditions for respiratory exchange ratio (RER) at VO2max [PT = 1.13
± 0.05, GT = 1.13 ± 0.05].
Fibrinolytic Potential
Two participants’ post-exercise blood samples were not obtained during the 2-min postexercise timeframe. These participants were excluded from the analysis of fibrinolytic variables.
One participant was a consistent outlier (greater than two standard deviations above the mean) for
tPA antigen and PAI-1 activity and was excluded from the analysis of fibrinolytic variables. A
Shapiro-Wilk test demonstrated that the data was not normally distributed for tPA antigen or PAI1 activity for at least one time point. These data were log-transformed prior to ANOVA. Further
analysis revealed that PAI-1 activity was still abnormally distributed after the log-transformation.
The next highest outlier was removed from the analysis of fibrinolytic variables and normalcy
was then achieved for PAI-1. The final sample size was 14 participants.
Figure 1 and 2 displays the mean tPA activity and tPA antigen response for the PT and
GT. A significant (P < 0.000) main effect was observed for time for tPA activity. tPA activity
significantly increased from pre-exercise [PT = 0.74 ± 0.08 IU ml-1, GT = 0.76 ± 0.07 IU ml-1] to
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post-exercise [PT = 19.5 ± 2.8 IU ml-1, GT = 19.8 ± 3.3 IU ml-1]. Compared to pre-exercise
values, there was no elevation in tPA activity 1-h post-exercise [PT = 0.69 ± 0.10 IU ml-1, GT =
0.69±0.06 IU ml-1]. There was no main effect for treatment (P = 0.91) and no treatment x time
interaction (P = 0.99) for tPA activity. A significant (P < 0.000) main effect for time was
observed for tPA antigen. tPA antigen significantly increased from pre-exercise [PT = 3.6 ± 0.46
ng ml-1, GT = 4.8 ± 1.0 ng ml-1] to post-exercise [PT = 15.4 ± 1.8 ng ml-1, GT = 20.0 ± 3.1 ng ml1

]. One hour post-exercise tPA antigen was reduced to a level not significantly different than pre-

exercise values [PT = 4.0 ± 0.52 ng ml-1, GT = 4.8 ± 0.80 ng ml-1] There was no main effect for
treatment (P = 0.16) and no treatment x time interaction (P = 0.89) for tPA antigen.
Figure 3 displays the mean PAI-1 activity response for the PT and GT. A significant (P <
0.000) main effect was observed for time. PAI-1 activity significantly decreased from preexercise [PT = 0.63 ± 0.10 ng ml-1, GT = 0.92 ± 0.22 ng ml-1] to post-exercise [PT = 0.16 ± 0.05
ng ml-1, GT = 0.32 ± 0.13 ng ml-1]. There was no difference in pre-exercise PAI-1 activity and
PAI-1 activity 1-h post-exercise [PT = 0.88 ± 0.17 ng ml-1, GT = 0.97 ± 0.21 ng ml-1]. There was
no significant main effect for treatment (P = 0.40) and no treatment x time interaction (P = 0.617)
for PAI-1 activity.
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Figure 1. Placebo (white bars) and garlic (gray bars) mean (SE) plasma levels of tPA Activity (IU ml-1) pre-exercise, post-exercise, and 1-hour postexercise. *- Significantly higher than pre-exercise (P<0.05).
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Figure 2. Placebo (white bars) and garlic (gray bars) mean (SE) plasma levels of tPA antigen (ng ml-1) pre-exercise, post-exercise,
exercise, and 11-hour postexercise. *- Significantly higher than pre-exercise (P<0.05).
<0.05).
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Figure 3. Placebo (white bars) and garlic (gray bars) mean (SE) PAI-1 activity (ng ml-1) pre-exercise, post-exercise, and 1-hour post-exercise.
*- Significantly higher than pre-exercise (P<0.05).
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Chapter Five
Discussion
The primary finding of this study is that acute garlic supplementation does not improve
the fibrinolytic potential or the fibrinolytic response to exercise in young, healthy, endurancetrained men. These results support the findings of another randomized, placebo controlled, double
blind study by Legnani and co-workers (1993) where no improvements in tPA activity were
observed with acute garlic supplementation. Both studies had a young, healthy, participant pool
which supplemented with 900 mg of garlic and had their fibrinolytic profile examined after
approximately 4 hours.
In contrast, several studies have described enhancement of the fibrinolytic system within
a few hours after the consumption of garlic. Bordia and colleagues (1975) measured global
fibrinolytic activity, using the euglobulin clot lysis method, following the administration of either
50 grams of garlic along with 100 grams of butter or only 100 g of butter. After 3 hours there
was an observed 15% increase in fibrinolytic activity in the garlic trial but an observed 49%
decrease in fibrinolytic activity in the butter only trial. Chutani & Bordia (1981) found that
fibrinolytic activity, also measured via the euglobulin clot lysis method, increased 72% and 62%
after the administration of raw and fried garlic, respectively. Moreover, they saw the
enhancement maintained for up to 12 hours. Kiesewetter et al. (1990) measured fibrinolytic
potential following acute garlic supplementation and observed significant increases in tPA
activity five hours after the administration of 300 mg and 600 mg of garlic (56% and 51%,
respectively). Kiesewetter et al. (1990) also observed 600 mg of garlic to produce significant
elevations in tPA activity in all participants. Jung and coworkers (1991) measured fibrinolytic
potential following acute garlic supplementation and observed about an 86% increase in tPA
activity after five hours.
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The current study did not confirm these findings, possibly due to differences in the form
of garlic administered. Bordia et al. (1975) and Chutani & Bordia (1981) administered raw
garlic. The main sulfur compound in raw garlic is alliin (Amagase et al., 2001). When garlic is
cut or crushed, the enzyme alliinase rapidly lyses aliin to another sulfur compound known as
aliicin (Block, 1985). Alliicin is extremely unstable and cannot be detected in the blood or urine
after the consumption of raw garlic (Lawson et al., 1992). Allicin, perfused into rat livers, shows
a large first-pass effect whereby allicin is converted to the metabolite diallyl disfulfide (DADS)
(Egen-Schwind et al., 1992). Similar metabolites of allicin include the sulfides diallyl sulfide
(DAS) and diallyl trisulfide (DAT) (Amagase et al., 2001). Kiesewetter et al. (1990) and Jung et
al. (1991) administered commercial preparations of powdered garlic that had a standard 1.3%
alliin content. Garlic powder retains the same ingredients as raw garlic and, when exposed to
water, allinase rapidly converts alliin to allicin and subsequently the metabolites DAS, DADS,
and DAT (Amagase et al., 2001). Like allicin, these sulfur containing compounds are metabolized
quickly (Lawson et al., 1992), and therefore, they seemed unlikely to be the active ingredient that
enhanced the fibrinolytic system acutely. The supplement used in the present study, is a form of
aged garlic extract (AGE) that is standardized to s-allyl cysteine (SAC). SAC is formed from the
catabolism of γ-glutamyl cysteine, a sulfur containing compound separate from alliin (Amagase
et al., 2001). SAC is a stable, odorless, and water soluble compound garlic (Amagase et al.,
2001). Unlike DADS, SAC can be detected in the plasma, liver, and kidney after the oral
ingestion (Nagae et al., 1994). Because it is detectable in the blood and increases quantitatively
following the oral intake of garlic, it is used as a compliance marker in human studies (Steiner &
Li, 2001). SAC is also found in small quantities in raw garlic and garlic powder (Amagase et al.,
2001). Thus, it is possible that differences in the active ingredient alter the hemostatic changes
that occur with this form of garlic supplementation.
In addition to feeding 50 grams of garlic along with 100 grams of butter to 10 healthy
men, Bordia and coworkers (1975) also extracted garlic’s essential oil from 50 g of garlic and
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then administered the essential oil to the same participant population. After 3 hours there was an
observed 15% increase in fibrinolytic activity. The essential oil of garlic is commonly obtained
by one of two methods. The first method is steam distillation whereby whole garlic is put into
boiling water and the rising steam from the vessel is captured (Block, 1985). The second method
involves grinding whole garlic cloves, adding them to water, and then having the oil fraction
extracted in an organic solvent (Block, 1985; Amagase et al., 2001). Both of these processes
completely eliminate the water-soluble components of garlic, such as SAC, but yield DAS and
DADS (Block, 1985; Amagase et al., 2001). This suggests the acute enhancement in fibrinolytic
potential by garlic may be derived from DAS and DADS rather than SAC. Further research
should be conducted to better understand the relationship between the sulfur metabolites of alliin
and their effects on fibrinolytic potential. If the sulfur metabolites of alliin are the active
compounds in garlic which enhance fibrinolytic potential acutely, then inconsistencies in the
literature would be explained as these metabolites are difficult to standardize and metabolize
quickly. For instance Legnani & co-workers (1993) administered a comparable dosage of the
same commercial garlic preparation to a comparable young, healthy, participant sample across a
similar time course as Kiesewetter et al. (1990) and Jung et al. (1991), yet, could not confirm
their results.

DAS, DADS, DAT

Allicin

Alliinase
(Upon cut or rupture)

Alliin
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Figure 5.1: The chemical changes in two sulfur compounds of garlic. Garlic contains γ-glutamyl cysteine. Through the process of hydrolysis and
oxidation, γ-glutamyl cysteine can be converted to alliin. After cutting or rupturing of the garlic bulb, alliinase rapidly lyses alliin to allicin. Allicin
decompose rapidly to the other sulfur containing compounds diallyl sulfide (DAS), diallyl disulfide (DADS), and diallyl trisulfide (DAT). γglutamyl cysteines may also be converted to S-allylcysteine (SAC) via a separate pathway.

SAC
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It is unclear as to whether or not our selected participant population contributed to the
lack of an observed effect. Bordia & colleagues (1975) used a population of ten healthy males
between the ages of 30-50 years and observed a 15% increase in fibrinolytic activity three hours
after the ingestion of garlic. Chutani & Bordia (1981) used an older population of males, mean
age 47.9 years, with a history of coronary artery disease and observed a 72% increase in
fibrinolytic activity 6 hours after the ingestion of garlic. These two studies suggest age may have
precluded an observed enhancement in fibrinolysis in the present study. In addition, the findings
of Chutani & Bordia (1981) suggest a difference in health status may also have contributed to our
observed lack of an effect of garlic. However, the comparison of our study’s participants to the
participants in these studies is problematic. The outcome measure employed by Bordia &
colleagues (1975) and Chutani & Bordia (1981) was the euglobulin clot lysis time, which does
not directly measure changes in fibrinolytic variables. Two of the studies which measured tPA
activity did observe an increase in plasma tPA activity in a participant population similar to ours.
Kiesewettier & co-workers (1990) examined ten apparently healthy participants, three women
and seven men, with a mean age of 26.9 years and observed about a 50% increase in tPA activity
after 5 hours. Jung & co-workers (1991) also examined ten apparently healthy participants, seven
men and three women, with a mean age of 26.9 years and observed about an 86% increase in tPA
activity after 5 hours. However, Legnani & coworkers (1993) also examined ten apparently health
participants, three women and seven men, with a mean age of 25.5 years and did not observe an
enhancement in tPA activity or tPA antigen or a decrease in PAI-1 activity after 2,4, or 6 hours.
No details were given about the cardiorespiratory function of the participants in either the
Kiesewettier & co-workers (1990) study the Jung & co-workers (1991), or the Legnani &
coworkers (1993) study. Future research should be conducted to better evaluate the relationships
between age, training status, and the effects of acute garlic supplementation on fibrinolytic
potential.
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An unexpected secondary finding of the present study is that acute garlic supplementation
causes a slight but significant increase in VO2max in young, healthy, trained males without
significantly increasing their treadmill time. Of the 17 participants whose gas exchange data was
analyzed, 13 of them achieved a higher relative VO2max during the garlic trial than during the
placebo trial. The average relative VO2max was 59.8 ml kg-1 min-1 and 61.4 ml kg-1 min-1 for the
placebo and garlic trials, respectively. Ince & colleagues (2000) administered a single dose of
garlic to 10 college aged endurance athletes. Five hours after the ingestion of the garlic tablets,
subjects underwent an incremental treadmill test according to the Bruce protocol. A significant
difference was observed for VO2max, 57.3 ml kg-1 min-1 for the garlic trial and 55.6 ml kg-1 min-1
for the placebo trial, and treadmill time, 1033.6 s for the garlic trial and 990 s for the placebo
trial. It was speculated that the observed differences between the garlic and placebo trials were
due to improvements in the fluidity of the blood. They argue for a “rheological advantage”
whereby whole-blood viscosity is decreased due to garlic-induced reductions in fibrinogen
concentration. It was suggested that this reduction in fibrinogen concentration translates into
better oxygen supply to the working musculature. Fibrinogen concentration was not measured by
Ince & colleagues (2000) nor was it measured in the current study. But, Stuart & Kenny (1980)
suggest hematocrit is the single most important determinant of whole-blood viscosity and in the
present study there was no significant difference observed in hematocrit values at any of the time
point across the two trials.
Nitric oxide (NO) is an important cellular messenger involved in the functioning of the
cardiovascular system which is synthesized from L- arginine by NO synthases (NOS) found in
endothelial cells, smooth muscle cells, and platelets (Moncada et al., 1991). A special type of
NOS, called endothelial constitutive (cNOS), is responsible for vasomotor tone (Moncada et al.,
1991). When cNOS is stimulated, NO is released from the endothelium (Kerwin et al., 1995).
This causes a rapid and transient relaxation of arteries and veins to improve flow through vessels
(Ignarro et al., 1991). Morihara & coworkers (2002) investigated the effect of AGE on NO
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production via measurement of NO metabolites in the plasma of mice. An increase in NO
production by 30-40% was observed from 15 to 60 minutes following the administration of AGE.
It was also noted that a selective cNOS inhibitor, given to the mice prior to AGE, neutralized the
enhanced NO production. This indicates that AGE increases NO production by activation of
cNOS. In a subsequent study by Morihara & coworkers (2006), they examined the effects of
AGE on NO production in rats engaging in repeated endurance exercise on a mechanical
treadmill 5 times per week for 4 weeks. AGE significantly increase NO metabolites 2-fold as
compared to the exercising control group which did not receive AGE. These studies suggest that
AGE enhances NO production resulting in dilation of blood vessels. This may in turn enhance
skeletal muscle perfusion and increase VO2max values. However, unpublished work from our lab
did not find enhanced flow mediated dilation in the brachial artery following garlic
supplementation, suggesting that it did not affect endothelium-derived NO. However, others have
observed enhanced vasodilation with acute garlic supplementation. Jung et al. (1991) observed an
increase in the diameter of erythrocyte column by 8.6% due to the vasodilation of pre-capillary
arterioles. Similarly, Wolf et al. (1990) observed a slight dilation of conjunctival vessels due to
garlic supplementation. Consequently AGE induced enhancement in vessel diameter may be
limited to the microcirculation only.
Interestingly, Morihara & coworkers (2006) also examined the impact of AGE on
succinate dehydrogenase (SDH) activity. SDH is a key enzyme involved in aerobic metabolism as
it plays a role in both the Kreb’s cycle and the electron transport chain (Oyedotun & Lemire,
2004). AGE significantly increased SDH activity by 40% in the gastrocnemius muscle of the rats
engaging in repeated endurance exercise on a mechanical treadmill 5 times per week for 4 weeks
as compared to the control exercising rats which did not receive AGE. This elevation in SDH
activity may indicate AGE enhances aerobic metabolism of skeletal muscle during exercise,
which in turn may account for the increase in VO2max observed in the present study.
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The functional importance of the observed improvements in VO2max is uncertain. The
present study found a 1.6 ml kg-1 min-1 increase in VO2max without a corresponding
improvement in treadmill time. Conversely, Ince & colleagues (2001) observed a 2 ml kg-1 min-1
increase in VO2max as well as a 53.6 s increase in treadmill time. Both studies used groups of
healthy trained college aged males. Future studies should seek to replicate the present findings to
see if the lack of improved treadmill time persists.
Some limitations of the present study exist. The exact time course of garlic’s
enhancement of the fibrinolytic system is not known. Baseline fibrinolytic measurements were
taken approximately three and a half hour after the administration of garlic. This assumes there
was not a transient rise and fall in fibrinolytic potential during this initial time period. This
limitation is unlikely, however, as the present study’s time course was modeled on previous
research which found no such transient rise and fall in fibrinolytic potential. The diet of the
participants the day before each treatment trial was not stringently controlled in the present study.
Dietary intake, particularly the intake of fat, can greatly influence fibrinolytic potential. Future
research should control the dietary intake of participants by having them choose from a
standardized meal plan option the day before each treatment trial. Participants in the present study
were also young, healthy, trained males. Therefore, it is unknown if a similar result would be
observed in untrained males, women, or clinical populations.
In summation, the present study does not support the hypothesis that acute
supplementation with garlic enhances the fibrinolytic potential or fibrinolytic response to exercise
in young, healthy, endurance trained males. Acute supplementation with garlic does result in a
small but significant increase in VO2max. It remains unclear if these improvements in VO2max
are of any functional importance.

Chapter Six
Summary
The primary aim of this study was to examine the potential effects of acute garlic
supplementation on fibrinolytic potential and the fibrinolytic response to exercise in young,
healthy, trained males with a randomized, double-blinded, crossover study design. We
hypothesized that acute garlic supplementation would: 1) increase participants’ plasma levels of
tPA activity and tPA antigen at rest, within 2-minutes post-exercise, and 1-hour post-exercise,
and 2) decrease participants’ plasma levels of PAI-1 activity at rest, within 2-minutes postexercise, and 1-hour post-exercise.
In contrast to our hypotheses, acute garlic supplementation was found not to increase
plasma levels of tPA activity or tPA antigen nor was acute garlic supplementation found to
decrease plasma levels of PAI-1 activity. A possible explanation for the lack of an effect may be
due to the form of garlic administered to participants. Notwithstanding, the results of this study
suggest that acute garlic supplementation does not alter the fibrinolytic potential or the
fibrinolytic response to exercise in young, healthy, trained males. Unexpectedly, acute garlic
supplementation was found to cause a small but statistically significant rise in VO2max without a
corresponding increase in treadmill time. This rise in VO2max may be due to increased nitric
oxide production in the microcirculation as well increase activity of the aerobic enzyme of
succinate dehydrogenase. It is not yet clear if this increase in VO2max is of any functional
importance.
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Appendix A
James Madison University
School of Kinesiology and Recreation Studies
Health Status Questionnaire
Instructions: Complete each question accurately. All information provided is confidential.
Part I: General Information
1. Study: The effects of acute garlic supplementation on the markers of fibrinolytic potential following a
bout of maximal aerobic exercise in young healthy untrained males
2. Participant Number:
3. Gender (circle one) Male Female
4. Date of Birth (Month/ Day/ Year)
Part II: Medical History
5. Circle any that died of heart attack before age 50: Father Mother Brother Sister Grandparent

6. Date of last medical exam: _____________ Last physical fitness test: _______________
7. Circle operations you have had: Back Heart Kidney Eyes
Lung

Joint

Neck

Ears

Hernia

Other ________________

8. Please circle any of the following for which you have been diagnosed or treated by a physician or health
professional:
Alcoholism
Diabetes
Anemia (sickle cell)
Emphysema
Anemia (other)
Epilepsy
Asthma
Eye Problems
Back Strain
Gout
Bleeding trait
Hearing Loss
Bronchitis, chronic
Heart Problem
Cancer
High Blood Pressure
Cirrhosis, liver
Hypoglycemia
Concussion
Hyperglycemia
Congenital defect
Infectious Mononucleosis
Other _____________________

Kidney Problems
Mental Illness
Muscular Injury
Neck Strain
Obesity
Orthopedic Injuries
Phlebitis
Rheumatoid arthritis
Stroke
Thyroid problem
Ulcer

9. Circle all medications taken in the last six months:
Blood thinner
Diabetic pill
Digitalis
Diuretic

Epilepsy medication
Heart-rhythm medication
High-blood pressure medication
Insulin

Nitroglycerin
Weight Loss Medication
Other __________________

10. Please list all vitamin, herbal, nutritional or other supplements that you are currently taking:

11. Any of these health symptoms that occur frequently is the basis for medical attention. Circle the
number indicating how often you have each of the following:
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5 = Very often

4 = Fairly often 3 = Sometimes 2 = Infrequently 1= Practically never

a. cough up blood
1 2 3 4 5

f. chest pain
1 2 3 4 5

b. abdominal pain
1 2 3 4 5

g. swollen joints
1 2 3 4 5

c. low back pain
1 2 3 4 5

h. feel faint
1 2 3 4 5

d. leg pain
1 2 3 4 5

i. dizziness
1 2 3 4 5

e. arm or shoulder pain
1 2 3 4 5

j. breathless on slight exertion
1 2 3 4 5

Part III: Health Related Behavior
12. Do you smoke? Yes No
13. If you are a smoker, indicate the number of smoked per day:
Cigarettes:
40 or more

20-39

10-19

1-9

Cigars or pipes only:
5 or more or any inhaled

less than 5, none inhaled

14. Do you exercise regularly? Yes No
15. How many times in a week do you spend at least 30 minutes in moderate to strenuous/vigorous
exercise?
1

2

3

4

5

6

7

days per week

16. Can you walk 4 miles briskly without fatigue? Yes No
17. Can you jog 3 miles continuously at a moderate pace without discomfort? Yes

No

18. Weight now: __________ lb. One year ago: __________ lb Age 21: __________ lb
19. Height: __________
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Appendix B
Consent to Participate in Research
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Christopher J. Womack, Ph.D & David
J. Lawton from James Madison University. The purpose of this study is to determine the effects of acute
garlic supplementation on markers of blood clotting following exercise.
Potential Risks & Benefits
If you choose to participate in this study, you will perform two separate treadmill exercise tests. The
investigator perceives the following are possible risks arising from your participation in the study: bad
breath, belches with the taste of garlic, nausea, diarrhea, vomiting, discomfort, dizziness, and in rare
occurrences, heart attack, stroke or death. The selection criteria used to obtain participants and the "Health
Status Questionnaire" are intended to minimize these risks. In healthy individuals, the risk of death during
vigorous exercise has been estimated at 1 death per year for every 18,000 individuals. Exercise testing will
be performed by CPR-certified individuals with an automated defibrillator in the room. Risks from blood
drawing include infection, bruising and mild discomfort.
Potential benefits from participation in this study include:
1) Contributing to the body of knowledge regarding the health benefits of garlic
2) Knowledge of your maximal aerobic capacity (VO2max)
Research Procedures
Should you decide to participate in this research study, you will be asked to sign this consent form once all
your questions have been answered to your satisfaction. This study consists of two separate exercise tests
performed on a treadmill. All testing will occur in Godwin Hall, room 209, on the campus of James
Madison University. All tests will be performed on three separate occasions, separated by a 10-day
washout period. You will also be breathing through a mouthpiece during all of the exercise tests so that we
can analyze your expired air to determine how much oxygen you are using. Your heart rate will be
monitored by a monitor that wraps around your chest.
VO2max Test: During the VO2max test, you will begin walking at a low intensity (2.5 mph). We will then
increase the speed of the treadmill by 0.5 mph each minute thereafter until 6.0 mph is reached. After this
point the treadmill speed will remain constant while the elevation is increased at a rate of 3.0% for each
minute until you indicate that you can no longer continue. Between test preparation, completion of the
exercise test, and the post-exercise period; this test should take approximately two hours.
Supplementation: Ten days prior to each test, you will be asked to refrain from eating garlic or foods that
contain the active ingredients of garlic. Immediately prior to each test, you will be asked to refrain from
food and beverages (except water) for 12 hours. In addition you will be asked to abstain from alcohol
consumption for 24 h prior to these tests The night before each test you will be given a packet containing
either a placebo or 900 mg of powdered garlic in gel tablets. Neither the investigator nor you will know
which treatment you received. The investigator will obtain the pills from someone with the knowledge of
whether you are receiving garlic or a placebo. That person will not make this known to the investigator
until after all testing is complete. You must ingest all of the tablets with a glass of water three hours prior to
testing.
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Blood Sampling: We will obtain about 10 ml of blood (about 2 tablespoons) prior to the treadmill test,
immediately after the treadmill test, and 1 h following the treadmill test. These blood samples will be
obtained from an arm vein.
Confidentiality
The results of this research will be presented at conferences and published in exercise science journals.
The results of this project will be coded in such a way that your identity will not be attached to the final
form of this study. The researcher retains the right to use and publish non-identifiable data. However, you
can ask that your data be removed from the study at any point prior to presentation and publication. While
individual responses are confidential, aggregate data will be presented representing averages or
generalizations about the responses as a whole. All data will be stored in a secure location accessible only
to the researcher. Final aggregate results will be made available to you upon request.
Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to participate. Should you choose to
participate, you can withdraw at any time without consequences of any kind. Your right to withdraw
includes the right to request that your blood samples be discarded at any time.
Questions
You may have questions or concerns during the time of your participation in this study, or after its
completion. If you have any questions about the study, contact David J. Lawton at
lawtondj@dukes.jmu.edu

If you have questions or concerns during the time of your participation in this study, or after its completion
or you would like to receive a copy of the final aggregate results of this study, please contact:

David J. Lawton
Kinesiology

Dr. Christopher Womack, Advisor
Kinesiology

James Madison University

James Madison University

lawtondj@dukes.jmu.edu

womackcx@jmu.edu
(540) 568-6145
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Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu
Giving of Consent
I have read this consent form and I understand what is being requested of me as a participant in this study.
I freely consent to participate. I have been given satisfactory answers to my questions. The investigator
provided me with a copy of this form. I certify that I am at least 18 years of age.

David J. Lawton
Name of Participant (Printed)

Name of Researcher(s) (Printed)

Name of Participant (Signed)

Name of Researcher(s) (Signed)

Date

Date
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Appendix C

International Physical Activity Questionnaire
We are interested in finding out about the kinds of physical activities that people do as part of their
everyday lives. The questions will ask you about the time you spent being physically active in the last 7
days. Please answer each question even if you do not consider yourself to be an active person. Please
think about the activities you do at work, as part of your house and yard work, to get from place to place,
and in your spare time for recreation, exercise or sport.

Think about all the vigorous activities that you did in the last 7 days. Vigorous physical activities refer to
activities that take hard physical effort and make you breathe much harder than normal. Think only about
those physical activities that you did for at least 10 minutes at a time.

1.

During the last 7 days, on how many days did you do vigorous physical activities like heavy
lifting, digging, aerobics, or fast bicycling?

_____

days per week

No vigorous physical activities
2.

Skip to question 3

How much time did you usually spend doing vigorous physical activities on one of those days?
_____

hours per day

_____

minutes per day

Don’t know/Not sure

Think about all the moderate activities that you did in the last 7 days. Moderate activities refer to
activities that take moderate physical effort and make you breathe somewhat harder than normal. Think
only about those physical activities that you did for at least 10 minutes at a time.
3.

During the last 7 days, on how many days did you do moderate physical activities like carrying
light loads, bicycling at a regular pace, or doubles tennis? Do not include walking.
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_____

days per week

No moderate physical activities

4.

Skip to question 5

How much time did you usually spend doing moderate physical activities on one of those days?
_____

hours per day

_____

minutes per day

Don’t know/Not sure

Think about the time you spent walking in the last 7 days. This includes at work and at home, walking to
travel from place to place, and any other walking that you might do solely for recreation, sport, exercise, or
leisure.

5.

During the last 7 days, on how many days did you walk for at least 10 minutes at a time?

_____

days per week

No walking

6.

Skip to question 7

How much time did you usually spend walking on one of those days?
_____

hours per day

_____

minutes per day

Don’t know/Not sure
The last question is about the time you spent sitting on weekdays during the last 7 days. Include time
spent at work, at home, while doing course work and during leisure time. This may include time spent
sitting at a desk, visiting friends, reading, or sitting or lying down to watch television.

7.

During the last 7 days, how much time did you spend sitting on a week day?
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_____

hours per day

_____

minutes per day

Don’t know/Not sure
This is the end of the questionnaire, thank you for participating
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Appendix D
24 Hour Food Log and Re-Call

Daily Food Record
Record all foods and liquids consumed in a single day. Please be as specific as possible
Date:
Time

Food/Drink Consumed and Method of Preparation

Amount
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